The 2006 STD Prevention Conference, Beyond The Hidden Epidemic: Evolution or Revolution? will be held May 8-11, 2006, at the Hyatt Regency Jacksonville (FL) Riverfront.
When you review immunization schedules with your adolescent patients this year, will a vaccine for human papillomavirus (HPV) be added to your discussion list? While no vaccine has yet been approved, recent scientific advances signal that such a vaccine soon may become a reality.
When you scan your next chart, it gives the medical history of a 19-year-old woman who has been sexually active with multiple partners and inconsistently uses condoms. She reports a painful or burning sensation when urinating and increased vaginal discharge. What is your next move?
Many of your patients may now be using the extended regimen oral contraceptive (OC) Seasonale (Barr Labs, Pomona, NY), where an active pill is taken for 84 days, followed by seven days of placebo pills. But what if there was a pill that would offer continuous dosing with no pill-free intervals?
Get ready to discuss questions about the safety of the Evra contraceptive patch (Ortho-McNeil Pharmaceutical, Raritan, NJ) now that the Food and Drug Administration (FDA) has revised the transdermal contraceptives labeling.
Authors: William J. Kennedy, DO, Fellow, Palliative Care Services, Mount Carmel Health, Columbus, OH; Philip H. Santa-Emma, MD, Medical Director, Palliative Care Services, Mount Carmel Health, Columbus, OH; and Robert M. Taylor, MD, Medical Director, Palliative Care Services, Mount Carmel Health, Columbus, OH. Peer Reviewer: Lynn McDonald, MD, Medical Director, Hospice of Kankakee Valley, Bourbonnais, IL.
Should Beta-Blockers Remain First Choice in the Treatment of Primary Hypertension?; Obstructive Sleep Apnea as a Risk Factor for Stroke and Death; Cholinesterase Inhibitors for Alzheimers Disease